TY - JOUR AU - Lee, Y. H. AU - Bang, H. AU - Kim, D. J. PY - 2016 DA - 2016// TI - How to establish clinical prediction models JO - Endocrinol Metab (Seoul) VL - 31 UR - https://doi.org/10.3803/EnM.2016.31.1.38 DO - 10.3803/EnM.2016.31.1.38 ID - Lee2016 ER - TY - JOUR AU - Garcia Rodriguez, L. A. AU - Perez Gutthann, S. PY - 1998 DA - 1998// TI - Use of the UK general practice research database for pharmacoepidemiology JO - Br J Clin Pharmacol VL - 45 UR - https://doi.org/10.1046/j.1365-2125.1998.00701.x DO - 10.1046/j.1365-2125.1998.00701.x ID - Garcia Rodriguez1998 ER - TY - JOUR AU - Stovner, L. J. AU - Zwart, J. A. AU - Hagen, K. AU - Terwindt, G. AU - Pascual, J. PY - 2006 DA - 2006// TI - Epidemiology of headache in Europe JO - Eur J Neurol VL - 13 UR - https://doi.org/10.1111/j.1468-1331.2006.01184.x DO - 10.1111/j.1468-1331.2006.01184.x ID - Stovner2006 ER - TY - JOUR AU - Antonaci, F. AU - Dumitrache, C. AU - Cillis, I. AU - Allena, M. PY - 2010 DA - 2010// TI - A review of current European treatment guidelines for migraine JO - J Headache Pain VL - 11 UR - https://doi.org/10.1007/s10194-009-0179-2 DO - 10.1007/s10194-009-0179-2 ID - Antonaci2010 ER - TY - JOUR AU - Tepper, S. J. AU - Spears, R. C. PY - 2009 DA - 2009// TI - Acute treatment of migraine JO - Neurol Clin VL - 27 UR - https://doi.org/10.1016/j.ncl.2008.11.008 DO - 10.1016/j.ncl.2008.11.008 ID - Tepper2009 ER - TY - JOUR AU - Loder, E. PY - 2010 DA - 2010// TI - Triptan therapy in migraine JO - N Engl J Med VL - 363 UR - https://doi.org/10.1056/NEJMct0910887 DO - 10.1056/NEJMct0910887 ID - Loder2010 ER - TY - STD TI - Ramadan NM (2007) Current trends in migraine prophylaxis. Headache 47 Suppl 1:S52-7 ID - ref7 ER - TY - JOUR AU - Kildemoes, H. W. AU - Sorensen, H. T. AU - Hallas, J. PY - 2011 DA - 2011// TI - The Danish National Prescription Registry JO - Scand J Public Health VL - 39 UR - https://doi.org/10.1177/1403494810394717 DO - 10.1177/1403494810394717 ID - Kildemoes2011 ER - TY - JOUR AU - Esserlind, A. AU - Christensen, A. AU - Steinberg, S. AU - Grarup, N. AU - Pedersen, O. AU - Hansen, T. PY - 2016 DA - 2016// TI - The association between candidate migraine susceptibility loci and severe migraine phenotype in a clinical sample JO - Cephalalgia VL - 36 UR - https://doi.org/10.1177/0333102415570492 DO - 10.1177/0333102415570492 ID - Esserlind2016 ER - TY - BOOK AU - Olesen, J. PY - 2006 DA - 2006// TI - International classification of headache disorders, (ICHD-2): current status and future revisions PB - SAGE Publications Sage UK CY - London, England ID - Olesen2006 ER - TY - JOUR AU - Kuhn, M. PY - 2008 DA - 2008// TI - Building predictive models in R using the caret package JO - J Stat Softw VL - 28 UR - https://doi.org/10.18637/jss.v028.i05 DO - 10.18637/jss.v028.i05 ID - Kuhn2008 ER - TY - JOUR AU - Bates, D. AU - Ashford, E. AU - Dawson, R. AU - Ensink, F. B. AU - Gilhus, N. E. AU - Olesen, J. PY - 1994 DA - 1994// TI - Subcutaneous sumatriptan during the migraine aura. Sumatriptan Aura study group JO - Neurology. VL - 44 UR - https://doi.org/10.1212/WNL.44.9.1587 DO - 10.1212/WNL.44.9.1587 ID - Bates1994 ER - TY - JOUR AU - Zhang, L. M. AU - Dong, Z. AU - Yu, S. Y. PY - 2016 DA - 2016// TI - Migraine in the era of precision medicine JO - Ann Transl Med VL - 4 UR - https://doi.org/10.21037/atm.2016.03.13 DO - 10.21037/atm.2016.03.13 ID - Zhang2016 ER - TY - STD TI - Capi M, Gentile G, Lionetto L, Salerno G, Cipolla F, Curto M et al (2018) Pharmacogenetic considerations for migraine therapies. Expert Opin Drug Metab Toxicol:14(11):1161–14(11):1167 ID - ref14 ER - TY - JOUR AU - Kojic, Z. AU - Stojanovic, D. PY - 2013 DA - 2013// TI - Pathophysiology of migraine--from molecular to personalized medicine JO - Med Pregl VL - 66 UR - https://doi.org/10.2298/MPNS1302053K DO - 10.2298/MPNS1302053K ID - Kojic2013 ER - TY - JOUR AU - Pomes, L. M. AU - Gentile, G. AU - Simmaco, M. AU - Borro, M. AU - Martelletti, P. PY - 2018 DA - 2018// TI - Tailoring treatment in Polymorbid migraine patients through personalized medicine JO - CNS Drugs VL - 32 UR - https://doi.org/10.1007/s40263-018-0532-6 DO - 10.1007/s40263-018-0532-6 ID - Pomes2018 ER - TY - JOUR AU - Ingason, A. AU - Rujescu, D. AU - Cichon, S. AU - Sigurdsson, E. AU - Sigmundsson, T. AU - Pietilainen, O. P. H. PY - 2011 DA - 2011// TI - Copy number variations of chromosome 16p13.1 region associated with schizophrenia JO - Mol Psychiatry VL - 16 UR - https://doi.org/10.1038/mp.2009.101 DO - 10.1038/mp.2009.101 ID - Ingason2011 ER - TY - JOUR AU - Ravyn, D. AU - Ravyn, V. AU - Lowney, R. AU - Nasrallah, H. A. PY - 2013 DA - 2013// TI - CYP450 pharmacogenetic treatment strategies for antipsychotics: a review of the evidence JO - Schizophr Res VL - 149 UR - https://doi.org/10.1016/j.schres.2013.06.035 DO - 10.1016/j.schres.2013.06.035 ID - Ravyn2013 ER - TY - JOUR AU - Ingelman-Sundberg, M. PY - 2004 DA - 2004// TI - Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future JO - Trends Pharmacol Sci VL - 25 UR - https://doi.org/10.1016/j.tips.2004.02.007 DO - 10.1016/j.tips.2004.02.007 ID - Ingelman-Sundberg2004 ER -